Some of em areclaim to help with potential muscle loss cause that is something that has been noted with the GLP-1 weight-loss drugs
Rossing P, Caramori ML, Chan JC, Heerspink HJ, Hurst C, Khunti K, Liew A, Michos ED, Navaneethan SD, Olowu WA, et al
While genetic variations in receptor expression may theoretically affect response, this is not currently used in clinical decision-making
There is no universal UK requirement to stop GLP-1 medications before all procedures
The L-cells that produce GLP-1 possess nutrient-sensing receptors that respond to specific molecular signals from digested food
Heres what our team is saying about this breakthrough: Sofwave gives us a way to address skin laxity thats only going to become more common as weight loss treatments grow